Literature DB >> 2501871

Importance of fibrin specificity in therapeutic thrombolysis and the rationale of using sequential and synergistic combinations of tissue plasminogen activator and pro-urokinase.

V Gurewich1.   

Abstract

Mesh:

Substances:

Year:  1989        PMID: 2501871     DOI: 10.1055/s-2007-1002694

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


× No keyword cloud information.
  2 in total

1.  Venous thrombolysis by tissue-type plasminogen activator in conjunction with the urokinase-fibrinogen covalent conjugate. Effects of potentiation and faster action in dogs.

Authors:  A V Maksimenko; E G Tischenko; A D Petrov; M L Petrova; V L Golubykh
Journal:  Appl Biochem Biotechnol       Date:  1996 Oct-Nov       Impact factor: 2.926

2.  Pro to Gly (P219G) in a silent glycosylation site results in complete glycosylation in tissue plasminogen activator.

Authors:  D T Berg; B W Grinnell
Journal:  Protein Sci       Date:  1993-01       Impact factor: 6.725

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.